EP3038643
Mótefni gegn CSF-1R
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.8.2014EP published:
1.5.2019EP application number:
14755668.2
EP translation filed:
5.6.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
25.8.2034Expiry date:
25.8.2026Next due date:
31.8.2026
Title:
ANTIBODIES AGAINST CSF-1R
Timeline
Today
26.8.2014EP application
1.5.2019EP Publication
5.6.2019Translation submitted
15.6.2019Registration published
25.8.2026Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allé de la Recherche 60, 1070 Brussels, BE
Inventor
Name:
CRAGGS, GrahamAddress:
SloughBerkshire SL1 3WE, GB
Name:
HERVÉ, Karine Jeannine MadeleineAddress:
Slough, Berkshire SL1 3WE, GB
Name:
MARSHALL, DianeAddress:
SloughBerkshire SL1 3WE, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201315487Date:
30.8.2013Country:
GB
Classification
Categories:
A61K 39/00, A61P 11/00, A61P 35/00, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 1.7.2019
Expires: 25.8.2020
Payer: Árnason Faktor
Number: 7
Paid: 8.7.2020
Expires: 25.8.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.7.2021
Expires: 25.8.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.7.2022
Expires: 25.8.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.7.2023
Expires: 25.8.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.7.2023
Expires: 25.8.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.7.2024
Expires: 25.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.7.2024
Expires: 25.8.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.8.2025
Expires: 25.8.2026
Payer: Árnason Faktor ehf.